ADVERTISEMENT
12th Biennial Meeting
12th Biennial Meeting of the International Andreas Gruentzig Society: Meeting Program
Session 1: Coronary
Chronic Stable Angina-QOL vs MACE Reduction Benefit With Intervention
Coronary Lesion Assessment: Are FFR and iFR It?
Can OCT Identify ACS Patients Who Don't Need Stents?
Session 2: Structural
Is Paravalvular Leak the Achilles Heel of TAVR and How to Obtain Best Outcomes
Valves and Other Devices for Structural Mitral Valve Disease
Devices for Functional MR: One Clip, Two Clip, Three Clip, Four?
Session 3: Endovascular
Aortic Frontiers: The Prophylactic Treatment of Uncomplicated Type B Dissection
Endovascular Drug Eluting Balloons vs. Stents: Is Provisional Stenting Back?
What to do with the Asymptomatic Carotid Stenosis?
Session 4: Emerging Therapies
Destination Therapy for Heart Failure: What to do When the Batteries Run Out?
Myocyte Recovery Strategies and Cell Therapies for Myocardial Regeneration Post MI
Novel Therapies for Plaque Inflammation
Session 6: Structural
PFO: Should Anyone be Closed and With What?
Penumbra Direct Aspiration System: Removing Clots for Acute Ischemic Stroke
Hybrid Imaging: Synergy and Co-registration of X-ray, CT and 3D Echo in the Interventional Suite
Session 7: Endovascular
Mechanical Devices for Acute Stroke Intervention: Why Did the Trials Fail?
Novel Lower Extremity Interventions: Chocolate TOBA, or Something Like That?
Session 9: Emerging Therapies
Devices for Diastolic Dysfunction: The Golden Parachute?
Session 11: Industry Roundtable
How to Approach the Increasing Worldwide Disconnect Between Evidence, Indication and Reimbursement?
Cost-Effectiveness Research: Sorely Needed for Interventional Therapies
ACOs: Industry’s Role in Bringing Providers and Payers Together
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement